Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AVI BioPharma and ImmunoTherapy announce preliminary results of phase II vaccine study

April 7, 1998

Melacine marketing application granted expedited review by EMEA

April 7, 1998

Campath-1H enters pivotal phase III testing stage

April 7, 1998

Prostate cancer immunotherapeutic evaluated in preclinical and clinical trials

April 6, 1998

Vaxcel acquires rights to cancer antigen

April 6, 1998

Preclinical data indicates efficacy of AltaRex's approach to cancer immunotherapy

April 2, 1998

Merck KGaA initiates worldwide cancer study with BEC2

April 2, 1998

Genentech receives fast track product designation for Herceptin

April 2, 1998

Dendreon's dendritic cell-based immunotherapy reported at AACR

March 30, 1998

Novel fusion protein with potent activity in colon cancer models reported at AACR

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...